These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9457495)

  • 1. Comparison of the effects of NS-21 and terodiline on the QTc interval in dogs.
    Natsukawa T; Matsuzaki T; Hayashi S; Ukai Y; Yoshikuni Y; Kimura K
    Gen Pharmacol; 1998 Jan; 30(1):137-42. PubMed ID: 9457495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac electrophysiological actions of NS-21 and its active metabolite, RCC-36, compared with terodiline.
    Hayashi S; Natsukawa T; Suma C; Ukai Y; Yoshikuni Y; Kimura K
    Naunyn Schmiedebergs Arch Pharmacol; 1997 May; 355(5):651-8. PubMed ID: 9151306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the anticholinergic drug with calcium antagonistic activity, (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate, on lower urinary tract function in decerebrated dogs.
    Kimura Y; Fukui H; Hamada K; Ogasawara T; Yamazaki C; Ukai Y; Yoshikuni Y; Kimura K
    Arzneimittelforschung; 1997 Feb; 47(2):182-9. PubMed ID: 9079238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the anticholinergic drug with calcium antagonistic activity, (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate, on lower urinary tract function in rhesus monkeys.
    Kimura Y; Hamada K; Fukui H; Ogasawara T; Ukai Y; Yoshikuni Y; Kimura K
    Arzneimittelforschung; 1997 Feb; 47(2):189-94. PubMed ID: 9079239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects of NS-21, a novel drug for urinary incontinence, and its active metabolite, RCC-36, on L-type calcium currents in isolated guinea pig detrusor smooth muscle cells.
    Hayashi S; Natsukawa T; Ukai Y; Yoshikuni Y; Kimura K
    Naunyn Schmiedebergs Arch Pharmacol; 1997 May; 355(5):659-66. PubMed ID: 9151307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate. 3rd communication: plasma concentrations of the unchanged drug and its deethylated metabolite in rats, dogs and monkeys.
    Nakamura A; Hirota T; Sugihara K; Morino A
    Arzneimittelforschung; 1997 Feb; 47(2):169-74. PubMed ID: 9079236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic/pharmacodynamic assessment of the effects of E4031, cisapride, terfenadine and terodiline on monophasic action potential duration in dog.
    Webster R; Allan G; Anto-Awuakye K; Harrison A; Kidd T; Leishman D; Phipps J; Walker D
    Xenobiotica; 2001; 31(8-9):633-50. PubMed ID: 11569530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate. 1st communication: absorption, distribution and excretion after single administration of 14C-labeled compound to rats and dogs.
    Nakamura A; Sugihara K; Hirota T; Morino A; Ezumi Y; Takaichi M
    Arzneimittelforschung; 1997 Feb; 47(2):151-9. PubMed ID: 9079234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate. 4th communication: metabolism in rats and dogs.
    Hirota T; Nakamura A; Sugihara K; Morino A
    Arzneimittelforschung; 1997 Feb; 47(2):175-81. PubMed ID: 9079237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of terodiline and a major metabolite in dogs with a correlation to a pharmacodynamic effect.
    Hallén B; Grälls M; Brötell H; Strömberg S
    Pharmacol Toxicol; 1990 May; 66(5):373-81. PubMed ID: 2371244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo and in vitro electrophysiologic effects of terodiline on dog myocardium.
    Pressler ML; Warner MR; Rubart M; Rardon DP; Zipes DP
    J Cardiovasc Electrophysiol; 1995 Jun; 6(6):443-54. PubMed ID: 7551314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of cardiac inward-rectifier K+ current by terodiline.
    Jones SE; Kasamaki Y; Ogura T; Shuba LM; McCullough JR; McDonald TF
    Eur J Pharmacol; 1999 Apr; 370(3):319-27. PubMed ID: 10334509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concentration dependent cardiotoxicity of terodiline in patients treated for urinary incontinence.
    Thomas SH; Higham PD; Hartigan-Go K; Kamali F; Wood P; Campbell RW; Ford GA
    Br Heart J; 1995 Jul; 74(1):53-6. PubMed ID: 7662454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticholinergic and calcium antagonistic activities of NS-21 contribute to the inhibition of rat urinary bladder contractions.
    Hamada K; Sasaki Y; Taniguchi N; Fukui H; Miyatsuka Y; Kimura Y; Ukai Y; Yoshikuni Y; Kimura K
    Gen Pharmacol; 1997 Nov; 29(5):771-8. PubMed ID: 9347324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Toxicokinetics of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate (NS-21), a novel drug for urinary frequency and incontinence, in mice and rats during 13-week dietary administration].
    Nakazawa M; Kitayama E; Adachi T; Yoshida M; Ishibashi S; Yoshikawa K; Kajihara T; Iwakura K; Sumi N
    J Toxicol Sci; 1997 Apr; 22 Suppl 1():177-85. PubMed ID: 9170607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intraperitoneal single-dose toxicity studies of active metabolite, optical isomers, hydrolysis products and bi-product of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate(NS-21), a novel drug for urinary frequency and incontinence, in mice].
    Nishimura N; Kobayashi J; Moro M; Katsumata T; Nishiguchi Y; Iwakura K; Sumi N
    J Toxicol Sci; 1997 Apr; 22 Suppl 1():15-25. PubMed ID: 9170601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the calcium-antagonistic effects of terodiline, nifedipine and verapamil.
    Larsson-Backström C; Arrhenius E; Sagge K
    Acta Pharmacol Toxicol (Copenh); 1985 Jul; 57(1):8-17. PubMed ID: 4050455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of terodiline hydrochloride in isolated rabbit detrusor].
    Abe M; Ono Y; Yamazaki Y; Ujiie A; Ikeda S
    Nihon Yakurigaku Zasshi; 1987 Jul; 90(1):33-40. PubMed ID: 3653802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Oral single-dose and 13-week repeat-dose toxicity studies of RCC-36, the active metabolite of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate(NS-21), a novel drug for urinary frequency and incontinence, in rats].
    Furukawa S; Kouyama H; Kikumori M; Taniguchi Y; Nishimori T; Ishibashi S; Iwakura K; Sumi N
    J Toxicol Sci; 1997 Apr; 22 Suppl 1():93-124. PubMed ID: 9170604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blocking action of terodiline on calcium channels in single smooth muscle cells of the guinea pig urinary bladder.
    Kura H; Yoshino M; Yabu H
    J Pharmacol Exp Ther; 1992 May; 261(2):724-9. PubMed ID: 1315864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.